Comparative performance of the two pooled cohort equations for predicting atherosclerotic cardiovascular disease

Alessandra M Campos-Staffico1, David Cordwin1, Venkatesh L Murthy2

  • 1Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, 48109, USA.

Atherosclerosis
|August 30, 2021
PubMed

Insights

Both the original and revised Pooled Cohort Equations (PCE) poorly predict atherosclerotic cardiovascular disease (ASCVD) risk. This study found no improvement in accuracy with the revised PCE for real-world patient data.

Area of Science:

  • Cardiology
  • Epidemiology
  • Health Informatics

Background:

  • Multivariable algorithms, such as the AHA/ACC Pooled Cohort Equations (PCE), are used to predict atherosclerotic cardiovascular disease (ASCVD) risk.
  • A systematic overestimation of risk was identified with the original PCE, leading to the proposal of a revised PCE.
  • Accurate ASCVD risk prediction is crucial for identifying high-risk patients and guiding preventative strategies.

Purpose of the Study:

  • To compare the accuracy of the original and revised PCE in predicting ASCVD risk.
  • To evaluate the performance of both PCE models in a large, real-world patient sample.
  • To examine potential effect modification by race and sex on PCE accuracy.

Main Methods:

  • Retrospective cohort study of 20,843 patients aged 40-75 without prior ASCVD.
  • Comparison of model fit, calibration, and discrimination using metrics like Bayesian Information Criterion (BIC), Hosmer-Lemeshow test, AUC, Brier score, and precision-recall analysis.
  • Analysis of race and sex subgroups to assess effect modification.

Main Results:

  • Both PCE models demonstrated poor calibration (Hosmer-Lemeshow χ² > 20; p < 0.05) and discrimination (AUC < 0.7).
  • The revised PCE showed no significant improvement in discrimination compared to the original PCE (AUC: 0.677 vs 0.679; p = 0.357).
  • The original PCE indicated stronger positive risk prediction (ΔBIC > 10) than the revised PCE, despite overlapping calibration curves.

Conclusions:

  • Both original and revised PCE exhibit poor calibration and discrimination for ASCVD risk in a real-world patient population.
  • The revised PCE did not improve the accuracy of ASCVD risk assessment compared to the original PCE.
  • Findings suggest limitations in current PCE models for accurately identifying high-risk individuals for ASCVD.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
352
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
159
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
569
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
88
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
178
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
413